Status:
COMPLETED
Comparative Tolerability of Protease Inhibitors
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
HIV
Eligibility:
All Genders
18-64 years
Brief Summary
This study will be a retrospective observational study assessing identifiable tolerability problems in terms of their comparative incidence among Human Immunodeficiency Virus (HIV) patients treated wi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Initiated treatment with a Protease inhibitor (PI)-based Combination antiretroviral therapy (cART) regimen
- Between 18-64 years of age on the index date
- At least 6 months of continuous enrollment and pharmacy benefits prior to the index date
- At least 6 months of continuous enrollment and pharmacy benefits following the index date
- At least 1 medical claim during the 6-month follow-up period
Exclusion
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
26000 Patients enrolled
Trial Details
Trial ID
NCT01450618
Start Date
March 1 2011
End Date
October 1 2012
Last Update
December 5 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.